✕
Login
Register
Back to News
Avalyn Completes Target Enrollment In Phase 2b MIST Trial Of AP01
Benzinga Newsdesk
www.benzinga.com
Positive 75.1%
Neg 0%
Neu 0%
Pos 75.1%
Comments
No comments yet. Be the first!
Join the discussion
Login to comment
Login to comment